Question: I was just diagnosed with lung cancer. My doctor told me that I should have biomarker testing done to determine the best treatment for me. What are biomarkers, and why will testing for them affect my treatment options? [...]
Question: "I’ve seen commercials for immunotherapy as a treatment for lung cancer. How does it work? How do I know if it’s a good treatment for me?" Answer: Immunotherapy is a type of cancer treatment that helps the body’s [...]
Author: Daniel A. Saez, MSc, Manager, LungMATCH Navigation Program, GO2 for Lung Cancer Immunotherapy, a type of treatment that helps the body’s own immune system fight cancer, is often discussed as a first line of treatment for people with [...]
By Andrew Ciupek, PhD, Senior Manager, Clinical Research, GO2 for Lung Cancer and Daniel A. Saez, MSc, Navigator, Treatment & Trials, GO2 for Lung CancerNew Hope for Patients with KRASUntil recently, the KRAS mutation was considered un-targetable in most types [...]
By Rashmi Acharya, MS, Coordinator, Science & Research, GO2 for Lung CancerChemotherapy has been the standard treatment option for Non-Small Cell Lung Cancer (NSCLC) without actionable biomarkers. Recently, immunotherapy treatments have been added into the treatment mix. Several studies presented [...]
We are pleased to announce that GO2 for Lung Cancer is part of a recently-awarded five-year grant from the National Cancer Institute as part of its new SeroNet initiative. This project seeks to uncover whether people with lung cancer, [...]
The lung cancer world now has therapies tied to individual biomarkers, making comprehensive biomarker testing an imperative at diagnosis. On August 18, our monthly Lung Cancer Living Room featured Dr. Benjamin Levy from Johns Hopkins University/Sidney Kimmel Comprehensive Cancer [...]